Clinical Trial Update: Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 flexible-dose titration add-on trial for major depressive disorder sponsored by Targacept has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• TC-5214 (TC-5214)

Snippet

Sponsor: Targacept Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED